Literature DB >> 17410813

Oncologist-patient discussion of adjuvant hormonal therapy in breast cancer: results of a linguistic study focusing on adherence and persistence to therapy.

Brad Davidson1, Victor Vogel, Lawrence Wickerham.   

Abstract

Although studies have proven the benefit of 5+ years of adjuvant hormonal therapy (AHT) for breast cancer, data show adherence and persistence with therapy are suboptimal. This observational linguistic study analyzed communication between breast cancer patients and their oncologists to determine how adherence was addressed and to identify areas where communication could be improved. Community-based oncologists were recruited by letter to participate. Researchers visited oncologists (n = 14) to record patient-oncologist interactions and conduct separate post-visit interviews. Comprehensive linguistic analyses of visits between 28 postmenopausal, early-stage breast cancer patients on or initiating hormonal therapy and their oncologists were conducted to determine the nature of discussions of adherence and persistence to therapy. Oncologist-patient discussions about AHT were generally good but did not address potential difficulties of remaining adherent with long-term therapy. Discussions of persistence were usually monologues addressing the current state of "study data" and were not linked to the patient, the importance of persistence, or how the study data related to her situation. Because the patient's cancer was framed as being "in the past," discussions resembled those of chronic management in preventive medicine. This more ad-hoc approach to adherence and persistence is a potential stumbling block for motivating patients to stay on hormonal therapy. Additionally, the oncologists participating in this study recognized that adherence to therapy is a problem but did not feel "their patients" fell into this pattern. In this office-based evaluation, minimal nurse interactions were observed, which increases the importance of oncologist-patient communication. The authors recommend that oncologists leverage the existing good communication with their patients by increasing the amount and quality of discussions around the importance of adherence and persistence to AHT.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17410813

Source DB:  PubMed          Journal:  J Support Oncol        ISSN: 1544-6794


  14 in total

1.  Aromatase inhibitor associated arthralgia: the importance of oncology provider-patient communication about side effects and potential management through physical activity.

Authors:  Kirsten A Nyrop; Leigh F Callahan; Christine Rini; Mary Altpeter; Betsy Hackney; Amy DePue; Anne Wilson; Arielle Schechter; Hyman B Muss
Journal:  Support Care Cancer       Date:  2016-01-12       Impact factor: 3.603

Review 2.  Racial/Ethnic and socioeconomic disparities in endocrine therapy adherence in breast cancer: a systematic review.

Authors:  Megan C Roberts; Stephanie B Wheeler; Katherine Reeder-Hayes
Journal:  Am J Public Health       Date:  2015-04-23       Impact factor: 9.308

3.  Fine-tuning the truth.

Authors:  Elisabeth E Elder; Raimund Jakesz
Journal:  World J Surg       Date:  2011-10       Impact factor: 3.352

Review 4.  Behavioral Interventions to Enhance Adherence to Hormone Therapy in Breast Cancer Survivors: A Systematic Literature Review.

Authors:  Alejandra Hurtado-de-Mendoza; Mark L Cabling; Tania Lobo; Chiranjeev Dash; Vanessa B Sheppard
Journal:  Clin Breast Cancer       Date:  2016-03-31       Impact factor: 3.225

5.  Patient adherence to aromatase inhibitor treatment in the adjuvant setting.

Authors:  S Verma; Y Madarnas; S Sehdev; G Martin; J Bajcar
Journal:  Curr Oncol       Date:  2011-05       Impact factor: 3.677

6.  In-office discussions of migraine: results from the American Migraine Communication Study.

Authors:  Richard B Lipton; Steven R Hahn; Roger K Cady; Jan Lewis Brandes; Suzanne E Simons; Philip A Bain; Meaghan R Nelson
Journal:  J Gen Intern Med       Date:  2008-05-06       Impact factor: 5.128

7.  Persistence with bisphosphonates in patients with metastatic breast cancer: a retrospective database analysis.

Authors:  P Hadji; V Ziller; J Kyvernitakis; N Schmidt; K Kostev
Journal:  J Cancer Res Clin Oncol       Date:  2013-04-04       Impact factor: 4.553

8.  Adherence to adjuvant hormone therapy in low-income women with breast cancer: the role of provider-patient communication.

Authors:  Yihang Liu; Jennifer L Malin; Allison L Diamant; Amardeep Thind; Rose C Maly
Journal:  Breast Cancer Res Treat       Date:  2012-12-23       Impact factor: 4.872

9.  Providers' Perspectives on Adherence to Hormonal Therapy in Breast Cancer Survivors. Is there a Role for the Digital Health Feedback System?

Authors:  Alejandra Hurtado de Mendoza; Mark Cabling; Asma Dilawari; Jeanine W Turner; Nicole Fernández; Alesha Henderson; Qi Zhu; Sara Gómez; Vanessa B Sheppard
Journal:  Health Technol (Berl)       Date:  2018-10-05

10.  Physicians' influence on breast cancer patient compliance.

Authors:  Karel Kostev; Lilia Waehlert; Achim Jockwig; Barbara Jockwig; Peyman Hadji
Journal:  Ger Med Sci       Date:  2014-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.